Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended Decembe... ( FARMINGDALE N.Y. Feb. 9 /- Misonix I...)

Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008

Date:2/9/2009

FARMINGDALE, N.Y., Feb. 9 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today reported financial results for the three and six months ended December 31, 2008. Michael A. McManus, Jr., President and Chief Executive Officer, and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call Monday, February 9, 2009 at 4:30pm to discuss the Company's second quarter and six months financial results.

The Company also reported the following financial and operational achievements:

$.03 diluted earnings per share and a 5.1% increase in revenue for the three months ended December 31, 2008.
$.07 diluted earnings per share and a 6.2% increase in revenue for the six months ended December 31, 2008.
Signed one year extension for LySonix(R) 3000 ultrasonic assisted liposuction product with Mentor Corporation which includes purchase minimums.
Signed three year distribution agreement with Alliance Lithomobile of Milano, Italy for the Sonablate 500(R) for prostate cancer on a fee-per-use arrangement.
Executed exclusive distribution agreements for the SonicOne(TM) wound debridement system, Bone Scalpel(TM) and Sonastar(TM) Neuroaspirator in Turkey, Greece, Netherlands and the United Kingdom. Each agreement includes purchase minimums.

Revenues for the three months ended December 31, 2008 were $12.2 million, a 5.1% increase when compared with revenues of $11.6 million for the three months ended December 31, 2007. The increase in revenues for the three months ended December 31, 2008 was due to a $909,000 increase in medical dev
'/>"/>

1

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. Misonix Schedules Second Quarter Fiscal Year 2009 Financial Results Conference Call; February 9, 2009 at 4:30 P.M. Eastern
2. Misonix Announces New HIFU Distribution Agreement for Italy
3. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
4. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
5. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
6. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
7. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results
10. Bioniche Reports Fiscal 2009 Second Quarter
11. GEN Reports on Strategies to Overcome Blood-Brain Barrier

Post Your Comments:

Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended Decembe...( FARMINGDALE N.Y. Feb. 9 /- Misonix I...),Health